Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Update on the Implications of New Psychoactive Substances in Public Health
Ana Y. Simão, Mónica Antunes, Emanuel Cabral, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4869-4869
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances
Stefania Chiappini, Giorgia Vaccaro, Alessio Mosca, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105691-105691
Open Access | Times Cited: 8
LCMS Detection and Characterization of In Vitro Metabolites of Isotonitazene, a Targeted Strategy for Novel Psychoactive Substance Control in Camel Racing
Jahfar Nalakath, Rasik Puzhithinipra Rasik, Ahmed Kadry, et al.
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 7
Closed Access
Epidemiology of New Psychoactive Substances in Relation to Traditional Drugs of Abuse in Clinical Oral Fluid Samples
Magnus Axelsson, Hanna Lövgren, Robert Kronstrand, et al.
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 2
Open Access
Identification of new psychoactive substances and their metabolites using non-targeted detection with high-resolution mass spectrometry through diagnosing fragment ions/neutral loss analysis
José Manuel Matey, Félix Zapata, Luis Manuel Menéndez-Quintanal, et al.
Talanta (2023) Vol. 265, pp. 124816-124816
Closed Access | Times Cited: 18
Tackling new psychoactive substances through metabolomics: UHPLC-HRMS study on natural and synthetic opioids in male and female murine models
Gaia Di Francesco, Camilla Montesano, Flaminia Vincenti, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
New Psychoactive Substances: Health and Legal Challenges
I.C.S. Santos, Daniela Maia, Ricardo Jorge Dinis‐Oliveira, et al.
Psychoactives (2024) Vol. 3, Iss. 2, pp. 285-302
Open Access | Times Cited: 3
Metabolic characterization of the new benzimidazole synthetic opioids - nitazenes
Gajanan Raosaheb Jadhav, Pius S. Fasinu
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Simultaneous quantification of 106 drugs or their metabolites in nail samples by UPLC-MS/MS with high-throughput sample preparation: Application to 294 real cases
Peipei Liu, Wenjuan Liu, Hongwei Qiao, et al.
Analytica Chimica Acta (2022) Vol. 1226, pp. 340170-340170
Closed Access | Times Cited: 20
New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions
Chinaza Godswill Awuchi, Patrick Maduabuchi Aja, Nancy Bonareri Mitaki, et al.
Journal of Chemistry (2023) Vol. 2023, pp. 1-36
Open Access | Times Cited: 8
A systematic review and meta-analysis of synthetic cathinone use and psychosis
Rishika R Daswani, Cassandra M. Choles, David D. Kim, et al.
Psychopharmacology (2024) Vol. 241, Iss. 5, pp. 875-896
Closed Access | Times Cited: 2
α-Pyrrolidinohexanophenone (α-PHP) and α-Pyrrolidinoisohexanophenone (α-PiHP): A Review
Pedro Dinis, João Miguel Franco, Cláudia Margalho
Life (2024) Vol. 14, Iss. 4, pp. 429-429
Open Access | Times Cited: 2
Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assay
Tanja M. Gampfer, Victoria Schütz, Philip Schippers, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 245, pp. 116187-116187
Open Access | Times Cited: 2
Fabrication of a Molecularly-Imprinted-Polymer-Based Graphene Oxide Nanocomposite for Electrochemical Sensing of New Psychoactive Substances
Xue Jiang, Fang-Sheng Wu, Xiaoyu Huang, et al.
Nanomaterials (2023) Vol. 13, Iss. 4, pp. 751-751
Open Access | Times Cited: 6
The novel psychoactive substances epidemic: A scientometric perspective
Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, et al.
Addiction Neuroscience (2022) Vol. 5, pp. 100060-100060
Open Access | Times Cited: 10
PS2MS: A Deep Learning-Based Prediction System for Identifying New Psychoactive Substances Using Mass Spectrometry
Yi‐Ching Lin, Wei-Chen Chien, Yu-Xuan Wang, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 12, pp. 4835-4844
Open Access | Times Cited: 1
A comparative study of old versus novel psychoactive substances on craving, perceived stigma and suicidal risk among rural‐dwelling patients with substance abuse
Rasha Salah Eweida, Mahmoud Abdelwahab Khedr, Rasha Mohamed Hussein
Journal of Psychiatric and Mental Health Nursing (2024) Vol. 31, Iss. 6, pp. 1046-1056
Closed Access | Times Cited: 1
Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers
Stefano D’Errico, Martina Zanon, Davide Radaelli, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1936-1936
Open Access | Times Cited: 9
New Psychoactive Substances: A Potential Threat to Developing Countries
Mehedi Hasan, Shahjahan Ali Sarker
Addiction and Health (2023) Vol. 15, Iss. 2, pp. 136-143
Open Access | Times Cited: 4
The Therapeutic Potential of Amphetamine-like Psychostimulants
Bruno Pires, Luana M. Rosendo, Ana Teresa Brinca, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2180-2180
Open Access | Times Cited: 4
Understanding the evolving nature of novel psychoactive substances: Mapping 10 years of research
Alessandro Carollo, Ornella Corazza, Olivier Rabin, et al.
Emerging Trends in Drugs Addictions and Health (2023) Vol. 3, pp. 100055-100055
Open Access | Times Cited: 3
Current Design of New Psychoactive Substances
Francesco Paolo Busardò, Simona Zaami
Current Pharmaceutical Design (2022) Vol. 28, Iss. 15, pp. 1211-1212
Closed Access | Times Cited: 5
A Comprehensive Analysis of Legislative Strategies for New Psychoactive Substances: The Brazilian Panorama
Bruno Pereira dos Santos, Letícia Birk, Patricia de Souza Schwarz, et al.
Psychoactives (2023) Vol. 2, Iss. 3, pp. 242-255
Open Access | Times Cited: 2
Microextraction by Packed Sorbent as a Clean-up Approach for the Determination of Ketamine and Norketamine in Hair by Gas Chromatography--Tandem Mass Spectrometry
Ana Y. Simão, Patrik Oliveira, Luana M. Rosendo, et al.
Journal of Analytical Toxicology (2022) Vol. 47, Iss. 3, pp. 227-235
Closed Access | Times Cited: 4
Target and suspect screening of psychoactive substances in seizures and oral fluid exploiting retention time prediction and LC-MS/MS analysis
Gaia Di Francesco, Flaminia Vincenti, Camilla Montesano, et al.
Analytica Chimica Acta (2024) Vol. 1303, pp. 342529-342529
Closed Access
Interactive Properties of Alkaloids from Datura stramonium, Moringa oleifera, and Carica papaya with Human Receptor Proteins of Psychoactive Compounds from Cannabis sativa and Nicotiana tabacum

Tropical Journal of Natural Product Research (2024) Vol. 8, Iss. 7
Open Access
Page 1 - Next Page

Scroll to top